跳转至内容
Merck
CN

跳至

R9653

Sigma-Aldrich

RC-3095

≥95% (HPLC), lyophilized powder

别名:

D-Tpi-Gln-Trp-Ala-Val-Gly-His-Leu-Y(CH2-NH)-Leu-NH2 三氟乙酸盐, (3R)-2,3,4,9-四氢-1H-吡啶并[3,4-b]吲哚-3-羰基-L-谷氨酰胺酰基L-色氨酰-L-丙氨酰-L-valylglycyl-L-组氨- L-亮氨酰-Ψ(CH2-NH)-L-亮氨酰胺三氟乙酸盐,(D-Tpi6,Leu13Ψ(CH2-NH)-Leu14)铃蟾肽(6-14),D-Tpi-Gln- Trp-Ala-Val-Gly-His-Y(CH 2 -NH)-Leu-NH 2 三氟乙酸盐 三氟乙酸盐, (D-Tpi6,Leu13 Ψ(CH2-NH)-Leu14)铃蟾肽(6-14)

登录查看公司和协议定价

选择尺寸

1 MG
¥2,049.74

¥2,049.74

目录价¥6,832.48节省 70%

预计发货时间2025年7月21日详情

新价格,新优惠!

获取大包装报价

选择尺寸

变更视图
1 MG
¥2,049.74

About This Item

经验公式(希尔记法):
C56H79N15O9 · xC2HF3O2
CAS Number:
分子量:
1106.32 (free base basis)
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77

¥2,049.74

目录价¥6,832.48节省 70%

预计发货时间2025年7月21日详情

新价格,新优惠!

获取大包装报价
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

方案

≥95% (HPLC)

表单

lyophilized powder

颜色

white to off-white

储存温度

−20°C

SMILES字符串

OC(=O)C(F)(F)F.CC(C)C[C@@H](CN[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]4Cc5c(CN4)[nH]c6ccccc56)C(C)C

InChI

1S/C56H79N15O9.C2HF3O2/c1-29(2)18-35(25-61-42(50(58)74)19-30(3)4)66-55(79)45(21-34-24-59-28-64-34)68-48(73)27-63-56(80)49(31(5)6)71-51(75)32(7)65-54(78)44(20-33-23-60-39-14-10-8-12-36(33)39)70-52(76)41(16-17-47(57)72)69-53(77)43-22-38-37-13-9-11-15-40(37)67-46(38)26-62-43;3-2(4,5)1(6)7/h8-15,23-24,28-32,35,41-45,49,60-62,67H,16-22,25-27H2,1-7H3,(H2,57,72)(H2,58,74)(H,59,64)(H,63,80)(H,65,78)(H,66,79)(H,68,73)(H,69,77)(H,70,76)(H,71,75);(H,6,7)/t32-,35-,41-,42-,43+,44-,45-,49-;/m0./s1

InChI key

ZHNRKEKBKBWCMF-RWWZSYIDSA-N

Amino Acid Sequence

(D-TPI6, LEU13 y(CH2-NH)-LEU14)BOMBESIN (6-14)

生化/生理作用

RC-3095 是一种有效的 BB2(GRP 偏好)铃蟾肽受体拮抗剂。

包装

空气敏感

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)

法规信息

新产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Fabricia Petronilho et al.
Inflammation research : official journal of the European Histamine Research Society ... [et al.], 59(9), 783-789 (2010-04-07)
We report the effects of the gastrin-releasing peptide (GRP) receptor antagonist RC-3095 in an acute inflammation model induced by carrageenan. Male Wistar rats received saline or saline containing 2% lambda-carrageenan into the pleural cavity, with some also receiving RC-3095 3
Gislaine T Rezin et al.
Basic & clinical pharmacology & toxicology, 108(3), 214-219 (2010-12-09)
The pathophysiology of gastritis involves an imbalance between gastric acid attack and mucosal defence. In addition, the gastric mucosal injury results in adenosine triphosphate (ATP) depletion leading to mitochondrial dysfunction. Several studies have shown the association of mitochondrial disorders with
David Valter Pereira et al.
Investigative ophthalmology & visual science, 50(11), 5300-5303 (2009-06-12)
Some studies have shown the role of gastrin-releasing peptide (GRP) on the production and release of cytokines both in animal models and in humans with inflammatory diseases, but there are no reports on the effects of GRP in ocular inflammatory
Vanessa A Garcia et al.
Behavioural brain research, 214(2), 456-459 (2010-08-04)
Alterations in attachment behavior might play a role in the dysfunction in social behavior displayed by autistic infants. Here we show that neonatal gastrin-releasing peptide receptor (GRPR) blockade induces a reduction in maternal odor preference, a task involving attachment behavior
Juliana Presti-Torres et al.
Journal of neural transmission (Vienna, Austria : 1996), 119(3), 319-327 (2011-08-19)
We have previously shown that pharmacological blockade of the gastrin-releasing peptide receptor (GRPR) during the neonatal period in rats produces behavioral features of developmental neuropsychiatric disorders. Here, we show that social interaction deficits in this model are reversed by the

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持